Design and in-silico studies of abacavir analogues as Anti-DENV-2 NS5 methyltransferase

Design and in-silico studies of abacavir analogues as Anti-DENV-2 NS5 methyltransferase

Researchers have demonstrated substantial biological activity of the FDA-approved antiHIV drug "abacavir" against the cancer cell line and SARS-CoV-2. Using computational analysis, the most potent abacavir analogs were chosen in this investigation to find an anti-DENV inhibitor against the...

Full description

Bibliographic Details
Main Authors: Roney, Miah, Mohd Fadhlizil Fasihi, Mohd Aluwi
Format: Article
Language:English
Published: AMG Transcend Association 2025
Subjects:
QH301 Biology
RC Internal medicine
RM Therapeutics. Pharmacology
Online Access:http://umpir.ump.edu.my/id/eprint/45105/
http://umpir.ump.edu.my/id/eprint/45105/1/Design%20and%20in-silico%20studies%20of%20abacavir%20analogues%20as%20Anti-DENV-2%20NS5.pdf

Internet

http://umpir.ump.edu.my/id/eprint/45105/
http://umpir.ump.edu.my/id/eprint/45105/1/Design%20and%20in-silico%20studies%20of%20abacavir%20analogues%20as%20Anti-DENV-2%20NS5.pdf

Similar Items